
Sign up to save your podcasts
Or


Once considered a problem for high-income countries, being overweight is now on the rise in low- and middle-income parts of the world. At least 2.5 billion adults are now overweight or obese.
What’s causing this collective weight gain?
And if 2023 was the year of hype about weight-loss drugs like Ozempic, 2024 felt like the year of acceptance. We find out why weight-loss drugs are here to stay.
This week we’re joined by health journalist and Radio National presenter Tegan Taylor.
By ABC4.4
105105 ratings
Once considered a problem for high-income countries, being overweight is now on the rise in low- and middle-income parts of the world. At least 2.5 billion adults are now overweight or obese.
What’s causing this collective weight gain?
And if 2023 was the year of hype about weight-loss drugs like Ozempic, 2024 felt like the year of acceptance. We find out why weight-loss drugs are here to stay.
This week we’re joined by health journalist and Radio National presenter Tegan Taylor.

209 Listeners

99 Listeners

74 Listeners

89 Listeners

45 Listeners

1,745 Listeners

832 Listeners

187 Listeners

771 Listeners

129 Listeners

60 Listeners

62 Listeners

44 Listeners

62 Listeners

301 Listeners

1,005 Listeners

128 Listeners

11 Listeners

192 Listeners

119 Listeners

243 Listeners

1,004 Listeners

46 Listeners